Rejuvel settles $85,000 of $335,000 placement of convertible debenture

Offer sells three-year convertibles with variable conversion price

By Devika Patel

Knoxville, Tenn., July 30 – Rejuvel Bio-Sciences, Inc. completed an $85,000 initial tranche of a $335,000 private placement of convertible debentures on July 28, according to an 8-K filed Wednesday with the Securities and Exchange Commission. The deal priced on July 24.

The three-year debenture is convertible into common stock at a price equal to 60% of the lowest closing price of the stock during the 20 consecutive trading days preceding conversion.

The Miami company makes skin care products.

Issuer:	Rejuvel Bio-Sciences, Inc.
Issue:	Convertible debentures
Amount:	$335,000
Maturity:	Three years
Conversion price:	60% of the lowest closing price of the stock during the 20 consecutive trading days preceding conversion
Warrants:	No
Pricing date:	July 24
Settlement date:	July 28 (for $85,000)
Stock symbol:	OTCBB: NUUU
Stock price:	$0.71 at close July 23
Market capitalization:	$34.04 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.